Search research articles
Contact Us
Filters
Showing results (1-10 of 78) with videos related to
Page
of 8
Sort By:
British Journal of Clinical Pharmacology
|
December 29, 2021
Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors
Wajd Alkabbani, John-Michael Gamble
Drug Design, Development and Therapy
|
July 21, 2021
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date
Wajd Alkabbani, John-Michael Gamble
Canadian Journal of Diabetes
|
December 8, 2022
Prescribing Trends of the Sodium-Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015-2021)
Wajd Alkabbani, John-Michael Gamble
Canadian Family Physician Medecin De Famille Canadien
|
April 14, 2022
Variation in bleeding risk estimates among online calculators: Cross-sectional study of apps used by and for patients with atrial fibrillation
Ryan Pelletier, Jeff Nagge, John-Michael Gamble
American Journal of Medicine Open
|
July 22, 2024
Peak performance: Putting type 1 diabetes management recommendations for athletes to the test
Bradley Grightmire, Wajd Alkabbani, John-Michael Gamble
The Canadian Journal of Hospital Pharmacy
|
August 15, 2024
Prescribing Trends for Oral Vancomycin and Fidaxomicin after Guideline and Formulary Changes in Ontario, Canada: An Interrupted Time-Series Analysis
Mira Maximos, Colleen Maxwell, John-Michael Gamble
Computers in Biology and Medicine
|
May 29, 2025
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation
Victor Gitman, Colleen Maxwell, John-Michael Gamble
American Journal of Epidemiology
|
March 22, 2021
Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events
Wajd Alkabbani, Ryan Pelletier, John-Michael Gamble
Healthcare Policy = Politiques De Sante
|
November 2, 2011
A comparison of drug coverage in alberta before and after the introduction of the national common drug review process
John-Michael Gamble, Dean T Eurich, Jeffrey A Johnson
BMJ Open
|
March 13, 2015
Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review
Hilary I Price, Meghan D Agnew, John-Michael Gamble
Page
of 8
Search research articles
Search
Showing results (1-10 of 78) with videos related to
Sort By:
Page
of 8
British Journal of Clinical Pharmacology
|
December 29, 2021
Active-comparator restricted disproportionality analysis for pharmacovigilance signal detection studies of chronic disease medications: An example using sodium/glucose cotransporter 2 inhibitors
Wajd Alkabbani, John-Michael Gamble
Drug Design, Development and Therapy
|
July 21, 2021
Profile of Ipragliflozin, an Oral SGLT-2 Inhibitor for the Treatment of Type 2 Diabetes: The Evidence to Date
Wajd Alkabbani, John-Michael Gamble
Canadian Journal of Diabetes
|
December 8, 2022
Prescribing Trends of the Sodium-Glucose Cotransporter-2 Inhibitors Among Different Physician Specialties in Canada (2015-2021)
Wajd Alkabbani, John-Michael Gamble
Canadian Family Physician Medecin De Famille Canadien
|
April 14, 2022
Variation in bleeding risk estimates among online calculators: Cross-sectional study of apps used by and for patients with atrial fibrillation
Ryan Pelletier, Jeff Nagge, John-Michael Gamble
American Journal of Medicine Open
|
July 22, 2024
Peak performance: Putting type 1 diabetes management recommendations for athletes to the test
Bradley Grightmire, Wajd Alkabbani, John-Michael Gamble
The Canadian Journal of Hospital Pharmacy
|
August 15, 2024
Prescribing Trends for Oral Vancomycin and Fidaxomicin after Guideline and Formulary Changes in Ontario, Canada: An Interrupted Time-Series Analysis
Mira Maximos, Colleen Maxwell, John-Michael Gamble
Computers in Biology and Medicine
|
May 29, 2025
Enhancing search strategies for systematic reviews on drug Harms: An evaluation of the utility of ChatGPT in error detection and keyword generation
Victor Gitman, Colleen Maxwell, John-Michael Gamble
American Journal of Epidemiology
|
March 22, 2021
Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events
Wajd Alkabbani, Ryan Pelletier, John-Michael Gamble
Healthcare Policy = Politiques De Sante
|
November 2, 2011
A comparison of drug coverage in alberta before and after the introduction of the national common drug review process
John-Michael Gamble, Dean T Eurich, Jeffrey A Johnson
BMJ Open
|
March 13, 2015
Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review
Hilary I Price, Meghan D Agnew, John-Michael Gamble
Page
of 8